Medytox, "Temporary Sales Suspension and Worst-Case Performance Expected Due to COVID-19 Virus" Stock Price 139,900 KRW (1.82%)

Medytox is trading at 139,900 KRW, up 1.82% from the previous day as of 10:32 AM on the 20th. The trading volume is 61,969 shares, which is about 17.77% of the previous day's volume. Medytox is known as a manufacturer and seller of pharmaceuticals and cosmetic pharmaceuticals.

On May 18, Hana Financial Investment analyst Minjeong Seon stated, "The decline in toxin exports due to the COVID-19 pandemic has led to a deterioration in Medytox's performance, and the resulting stock price drop is inevitable. However, the recent sharp decline caused by many uncertainties could rebound once those uncertainties are resolved. The ITC preliminary ruling will be announced on June 5, Eastern Time. After the announcement, a significant portion of the uncertainties surrounding Medytox is expected to be resolved." She set the target price for Medytox at 260,000 KRW.

Over the past five days, individual investors have net bought 55,357 shares of Medytox, while foreign investors and institutions have net sold 73,264 shares and net bought 13,150 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.